Sonendo Q3 2023 Earnings Report

Sonendo EPS Results

• Actual EPS: -$0.14
• Consensus EPS: -$0.14
• Beat/Miss: Met Expectations
• One Year Ago EPS: N/A

Sonendo Revenue Results

• Actual Revenue: $10.41 million
• Expected Revenue: $10.40 million
• Beat/Miss: Beat by +$10.00 thousand
• YoY Revenue Growth: N/A

Sonendo Announcement Details

• Quarter: Q3 2023
• Date: 11/8/2023
• Time: N/A

Sonendo (NYSE:SONX), a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.